You have 9 free searches left this month | for more free features.

Condition

Hepatocellular Carcinoma (1)

Non-small Cell Lung Cancer (1)

Overall Status

Completed (1)

Withdrawn (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Eli Lilly and Company (2)

Collaborator

Intervention

ly2181308 (2)

docetaxel (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

ly2181308

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

NSCLC Trial in Worldwide (Docetaxel, LY2181308)

Completed

Non-small Cell Lung Cancer

Docetaxel
LY2181308

Los Angeles, California
+35 more

Aug 28, 2019

Hepatocellular Carcinoma Trial in Worldwide (LY2181308)

Withdrawn

Hepatocellular Carcinoma

LY2181308

Los Angeles, California
+11 more

Aug 27, 2008